Frontiers Case report: Short-term eculizumab use in atypical HUS

Frontiers An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

(PDF) Atypical Hemolytic Uremic Syndrome Post-Kidney Transplantation: Two Case Reports and Review of the Literature

PDF) Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing

Optimal management of atypical hemolytic uremic disease: challenges an

Frontiers Recommendations for the individualised management of atypical hemolytic uremic syndrome in adults

Pregnancy associated atypical hemolytic uremic syndrome presenting with preeclampsia with HELLP syndrome and following treatment with Eculizumab

PDF) Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era

PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome

PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome